Loading the section…

KIDS: financial statements from SEC — TradeAlmanac

KIDS

OrthoPediatrics Corp.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	59M	61M	61M	52M	55M	53M
Cost of revenue	16M	16M	17M	14M	15M	12M
Gross profit	43M	45M	44M	38M	40M	41M
Research and development	2M	2M	2M	2M	3M	3M
Selling, general and administrative	31M	29M	30M	30M	26M	27M
Operating expenses	52M	55M	55M	49M	46M	46M
Operating income	−8M	−9M	−11M	−11M	−6M	−6M
Pre-tax income	−11M	−12M	−7M	−10M	−9M	−6M
Income tax	−171,000	−125,000	49,000	196,000	−1M	−18,000
Net income	−11M	−12M	−7M	−11M	−8M	−6M
Earnings per share	−0.45	−0.50	−0.30	−0.46	−0.34	−0.26
Earnings per share, diluted	−0.45	−0.50	−0.30	−0.46	−0.34	−0.26
Weighted average shares	24M	24M	23M	23M	23M	23M
Weighted average shares, diluted	24M	24M	23M	23M	23M	23M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	12M	20M	17M	45M	33M	44M	53M	31M
Short-term investments	37M	41M	41M

Cash flow

Metric	31/03/2026	31/03/2025
Operating cash flow	−3M	−4M
Depreciation and amortisation	6M	5M
Share-based compensation	4M	4M
Capital expenditure	2M	4M
Investing cash flow	−4M	−6M
Financing cash flow	−614,000

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator